Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.96 +0.22 (+0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Short-term Investments (2010 - 2026)

Updated

Ligand Pharmaceuticals (LGND) recorded Short-term Investments of $351.06 million in Q2 2026, up 97.9% from $177.35 million a year earlier but down 47.2% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Short-term Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Ligand Pharmaceuticals reported Short-term Investments of $558.59 million, up 203.8% from FY2024.

  • Annual Short-term Investments has a five-year compound annual growth rate of 9.0% (FY2020 to FY2025).
  • Across earlier years, Short-term Investments came in at $183.86 million in FY2024 (+24.8%), $147.36 million in FY2023 (-11.7%), $166.86 million in FY2022 (-48.1%) and $321.59 million in FY2021 (-11.5%).
  • Quarterly Short-term Investments has ranged from $117.29 million in Q3 2022 to $664.33 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Short-term Investments has increased for four consecutive quarters, with growth averaging 101.7% over the last eight quarters.
  • Peak year-over-year performance for Short-term Investments in the last five years was growth of 312.9% in Q1 2026, against a decline of 60.9% in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $664.33 million (Q1 2026), $558.59 million (Q4 2025) and $525.15 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Ligand Pharmaceuticals 6.03 Bn 2.50 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 351.06 Mn
Mar 31, 2026 664.33 Mn
Dec 31, 2025 558.59 Mn
Sep 30, 2025 525.15 Mn
Jun 30, 2025 177.35 Mn
Mar 31, 2025 160.91 Mn
Dec 31, 2024 183.86 Mn
Sep 30, 2024 156.02 Mn
Jun 30, 2024 208.79 Mn
Mar 31, 2024 260.50 Mn
Dec 31, 2023 147.36 Mn
Sep 30, 2023 171.23 Mn
Jun 30, 2023 190.60 Mn
Mar 31, 2023 193.94 Mn
Dec 31, 2022 166.86 Mn
Sep 30, 2022 117.29 Mn
Jun 30, 2022 142.66 Mn
Mar 31, 2022 189.01 Mn
Dec 31, 2021 321.59 Mn
Sep 30, 2021 299.78 Mn
API Access

Ligand Pharmaceuticals Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=LGND&period=max&api_key=YOUR_API_KEY